Henlius Reports Sustained Growth and Third Consecutive Year of Profitability in 2025

Henlius (2696.HK) has announced its annual financial results for the 2025 fiscal year, highlighting a period of sustained growth in both revenue and profit. This performance marks the third consecutive year of profitability for the company since reaching this milestone in 2023. The results underscore significant progress in the company's global operations and the successful validation of its innovative pipeline. Henlius continues to expand its international footprint, demonstrating the effectiveness of its global market strategy and operational excellence. The sustained financial health of the firm provides a strong positive signal for investor confidence within the biotech and healthcare sectors. Overall, the 2025 results reflect Henlius's commitment to long-term value creation through continuous innovation and strategic expansion.

Sources:prnewswire.comtipranks.comyoutube.comhenlius.commatrixbcg.comprnewswire.commarketscreener.comsimplywall.stnews.futunn.com